Lancet (London, England)

• 

  Publication Venue For

  • FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement? 2021
  • India's COVID-19 crisis: a call for international action..  397:2132-2135. 2021
  • Frozen shoulder..  397:372. 2021
  • Cancer and COVID-19..  396:1066. 2020
  • Recurrence of breast cancer after anaesthesia..  396:376-377. 2020
  • Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for the Global Burden of Disease Study 2017..  395:1779-1801. 2020
  • Ensuring global access to COVID-19 vaccines..  395:1405-1406. 2020
  • Department of Error.  394:918-918. 2019
  • Building a tuberculosis-free world: The Lancet Commission on tuberculosis..  393:1331-1384. 2019
  • Erratum: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)).  392:2170. 2018
  • Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health..  392:1434-1460. 2018
  • Lancet Commission on the Value of Death..  392:1291-1293. 2018
  • The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China..  391:2140-2184. 2018
  • Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study..  391:339-349. 2018
  • Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).  390:2549-2558. 2017
  • Listerism then and now.  389:1002-1003. 2017
  • Global health humanities: defining an emerging field..  388:2586-2587. 2016
  • Next generation maternal health: external shocks and health-system innovations..  388:2296-2306. 2016
  • Global surgery initiative in Greece: more than an essential initiative..  388:957. 2016
  • The economic burden of physical inactivity: a global analysis of major non-communicable diseases..  388:1311-1324. 2016
  • Protecting human security: proposals for the G7 Ise-Shima Summit in Japan..  387:2155-2162. 2016
  • Organ donation during the financial crisis in Greece..  387:1511-1512. 2016
  • Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956)).  387:1162. 2016
  • How much donor financing for health is channelled to global versus country-specific aid functions?.  386:2436-2441. 2015
  • Reduce short-lived climate pollutants for multiple benefits..  386:e28-e31. 2015
  • Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health..  386:1973-2028. 2015
  • Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development..  386:569-624. 2015
  • Erratum: Aligning incentives to fulfil the promise of personalised medicine Lancet (2015) 385 (2118-19)).  385:2576. 2015
  • Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking..  385:2400-2409. 2015
  • Strategic science with policy impact..  385:2445-2446. 2015
  • Disparities in worldwide treatment of kidney failure..  385:1926-1928. 2015
  • Dual RAAS blockade for kidney failure: hope for the future..  385:2018-2020. 2015
  • Essential surgery: key messages from Disease Control Priorities, 3rd edition..  385:2209-2219. 2015
  • Financial contribution to global surgery: an analysis of 160 international charitable organisations..  385 Suppl 2:S52. 2015
  • Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN sustainable development goal for health..  385:239-252. 2015
  • Erratum: On behalf of the SOLSTICE Investigators. Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial (The Lancet (2014) 384 (1187-1195)).  384:1186. 2014
  • Investing in health--authors' reply..  383:950-951. 2014
  • Childhood cancer, endocrine disorders, and cohort studies.  383:1950-1952. 2014
  • Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17)).  383:2212. 2014
  • Global health 2035: a world converging within a generation..  382:1898-1955. 2013
  • Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart..  382:1507-1513. 2013
  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention..  382:339-352. 2013
  • Health reform in Pakistan: a call to action..  381:2291-2297. 2013
  • Non-communicable diseases and injuries in Pakistan: strategic priorities..  381:2281-2290. 2013
  • A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3.  381:S106-S106. 2013
  • Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012).  381:204-204. 2013
  • Early-life prevention of non-communicable diseases..  381:3-4. 2013
  • Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58)).  381:204. 2013
  • Erratum: Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: A secondary, prespecifi ed analysis of the TRILOGY\ ACS trial (The Lancet (2013) 382 (605-613).  382:768. 2013
  • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010..  380:2197-2223. 2012
  • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010..  380:2163-2196. 2012
  • Technologies for global health..  380:507-535. 2012
  • A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies..  379:823-832. 2012
  • Contracts with patients in clinical practice..  379:7-9. 2012
  • Haemopoietic stem-cell transplantation for systemic sclerosis - Authors' reply.  379:219-220. 2012
  • Pay-for-performance and the Millennium Development Goals..  377:1383-1385. 2011
  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis..  375:2073-2081. 2010
  • Environmental health in China: progress towards clean air and safe water..  375:1110-1119. 2010
  • Ageing and health - Authors' reply.  375:26-27. 2010
  • Responding to China's hypertensive crisis..  374:1728-1729. 2009
  • Ageing populations: the challenges ahead..  374:1196-1208. 2009
  • James Vaupel: an innovator in the demography of ageing. Interview by Samuel Loewenberg..  374:1139. 2009
  • Cognitive estrangement, science fiction, and medical ethics..  371:1908-1909. 2008
  • New treatments for age-related macular degeneration - Authors' reply.  370:1480. 2007
  • PLoS Medicine and the pharmaceutical industry.  367:1318. 2006
  • The MANTRA II study – Authors' reply.  366:1770-1771. 2005
  • Depression as risk factor for mortality after coronary artery bypass surgery.  362:1501-1502. 2003
  • The CHARM programme.  362:1678-1679. 2003
  • Erratum: As this was before furosemide was widely available, I called for nasal oxygen, 2 mL of subcutaneous thiomerin, and a quarter of a grain of morphine (Lancet (April 26, 2003) 361 (1417).  362:836. 2003
  • Erratum: Physicians' willingness to participate in the process of lethal injection for capital punishment. Ann Intern Med (Lancet (2001) 135 (884-888)).  362:334. 2003
  • Gene expression predictors of breast cancer outcomes..  361:1590-1596. 2003
  • Two hard lessons..  361:1417. 2003
  • Telomere shortening in cultured autografts of patients with burns..  361:1345-1346. 2003
  • Primary angioplasty or thrombolysis for acute myocardial infarction?.  361:965-966. 2003
  • Primary angioplasty or thrombolysis for acute myocardial infarction?.  361:966-967. 2003
  • Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy.  361:969-969. 2003
  • Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production..  361:676-678. 2003
  • Increased nitric oxide production and protection from malaria..  361:609-610. 2003
  • Treatment options for genetically determined immunodeficiency..  361:541-542. 2003
  • Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study..  361:374-379. 2003
  • Increased nitric oxide production and protection from malaria.  361:610-610. 2003
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension in infants..  360:2076-2077. 2002
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension in infants.  360:2077-2077. 2002
  • Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy..  360:1662-1664. 2002
  • A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children..  360:1468-1475. 2002
  • Association between children's experience of socioeconomic disadvantage and adult health: a life-course study..  360:1640-1645. 2002
  • Gene therapy for SCID--a complication after remarkable progress..  360:1185-1186. 2002
  • Hypothyroidism in house officers..  360:879. 2002
  • Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum..  360:610-617. 2002
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn..  360:141-143. 2002
  • Absolute and relative truth in clinical trials..  359:1945-1946. 2002
  • A medical education..  359:636. 2002
  • Coronary reperfusion: numerators searching for denominators..  359:371-372. 2002
  • Detection of proximal colorectal cancers through analysis of faecal DNA..  359:403-404. 2002
  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials..  359:189-198. 2002
  • Sensitivity of a clinical examination to predict need for radiography in children with ankle injuries: a prospective study..  358:2118-2121. 2001
  • Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial..  358:1855-1863. 2001
  • Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study..  358:1134-1140. 2001
  • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction..  358:605-613. 2001
  • Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.  358:545-549. 2001
  • Drug-company sponsorship and the Declaration of Helsinki..  357:1448-1449. 2001
  • Drug-company sponsorship and the Declaration of Helsinki.  357:1448-1449. 2001
  • Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study..  357:1063-1068. 2001
  • Erratum: Intracranial haemorrhage with bolus thrombolytic agents (The Lancet (November 25) (1849)).  357:642. 2001
  • Towards a genomic-based diagnosis..  357:249-250. 2001
  • Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction..  357:21-28. 2001
  • Chimerism in children with juvenile dermatomyositis..  356:2156-2157. 2000
  • Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial..  356:2037-2044. 2000
  • Intracranial haemorrhage with bolus thrombolytic agents..  356:1849. 2000
  • Intracranial haemorrhage with bolus thrombolytic agents..  356:1848. 2000
  • Grey-matter lesions and dementia..  356:1686-1687. 2000
  • Aortic-valve stenosis..  356:1605. 2000
  • Randomisation in the SYMPHONY trial..  356:1521-1522. 2000
  • Randomisation in the SYMPHONY trial.  356:1521-1522. 2000
  • The AIDS epidemic: lessons learned?.  356:1204. 2000
  • Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group..  356:968-974. 2000
  • Cardiogenic shock complicating acute coronary syndromes..  356:749-756. 2000
  • The uncertainty principle and industry-sponsored research..  356:635-638. 2000
  • Meningococcal immunisation in Ghana..  355:2252. 2000
  • All that glitters is not gold..  355:1568-1569. 2000
  • Control of meningococcal disease in west Africa..  355:1184-1185. 2000
  • Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes..  355:337-345. 2000
  • Unrecognised Mycobacterium tuberculosis..  355:141. 2000
  • Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa..  355:30-33. 2000
  • Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting..  354:2019-2024. 1999
  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group..  354:1932-1939. 1999
  • Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial..  354:1493-1498. 1999
  • Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries..  354:1159-1163. 1999
  • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial..  354:716-722. 1999
  • Cholinergic therapy for Down's syndrome..  353:1064-1065. 1999
  • Jhum-jhum: neuropsychiatric symptoms in a Nepali village..  353:1070. 1999
  • Kidney cancer..  353:594. 1999
  • Prediction of cognitive decline in early Alzheimer's disease..  352:1678. 1998
  • A tooth per child?.  352:1386. 1998
  • Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade..  352:87-92. 1998
  • A tooth per child?.  352:204. 1998
  • Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group..  351:1451-1467. 1998
  • Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure..  351:1317-1319. 1998
  • Prenatal exposure to famine and health in later life..  351:1361. 1998
  • Prenatal exposure to famine and health in later life..  351:1360-1361. 1998
  • Magnesium in in-hospital cardiac arrest..  351:445-446. 1998
  • Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis..  351:266-267. 1998
  • Gastroenterology. Lasers come of age..  350 Suppl 3:SIII7. 1997
  • Future vaccines and a global perspective..  350:1767-1770. 1997
  • From antiphospholipid syndrome to antibody-mediated thrombosis..  350:1491-1493. 1997
  • Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff..  350:1272-1276. 1997
  • Osler and Ernulf's curse..  350:1245-1246. 1997
  • Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II..  349:1422-1428. 1997
  • Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study..  349:1429-1435. 1997
  • Early management of acute severe asthma..  349:1030. 1997
  • Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor..  349:775-776. 1997
  • Immunotherapy for HIV..  349:434. 1997
  • Immunotherapy for HIV.  349:434-434. 1997
  • Rapid self testing for HIV infection..  349:352-353. 1997
  • Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial..  349:75-78. 1997
  • Department of error: (New frontiers of immunotherapy for HIV, December 7 (1531)).  349:510. 1997
  • New frontiers of immunotherapy for HIV..  348:1531-1532. 1996
  • HIV vaccines: where we are and where we are going..  348:933-937. 1996
  • Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan..  348:83-85. 1996
  • Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease..  348:90-93. 1996
  • Returning home: reflections on the USA's response to the HIV/AIDS epidemic..  347:1673-1676. 1996
  • Presenilin-1 polymorphism and Alzheimer's disease..  347:1560. 1996
  • Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis..  347:1367-1371. 1996
  • Presenilin-1 polymorphism and Alzheimer's disease..  347:1186-1187. 1996
  • Alzheimer's disease in twins..  347:976. 1996
  • Alzheimer's disease in twins..  347:975-976. 1996
  • Mutation analysis of presenillin 1 gene in Alzheimer's disease..  347:130-131. 1996
  • c-ANCA as a marker of Wegener's disease - Reply.  347:118-118. 1996
  • A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis..  346:926-931. 1995
  • ApoE genotype and survival from intracerebral haemorrhage..  346:575. 1995
  • Seizure associated with zidovudine..  346:452. 1995
  • Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids..  346:371. 1995
  • Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease..  345:1600-1603. 1995
  • Identical-twin small-bowel transplant for desmoid tumour..  345:1577-1578. 1995
  • ISIS-4..  345:1372-1373. 1995
  • External examiners..  345:1093-1095. 1995
  • Smoking, Alzheimer's disease, and confounding with genes..  345:1054. 1995
  • Neuroleptic treatment and caudate plasticity..  345:734-735. 1995
  • Sex of editor in medical journals..  345:662. 1995
  • Smoking, Alzheimer's disease, and confounding with genes..  345:387. 1995
  • Apolipoprotein E in Creutzfeldt-Jacob disease..  345:69. 1995
  • Apolipoprotein E in Creutzfeldt-Jakob disease..  345:68. 1995
  • Dentatorubral-pallidoluysian atrophy and Haw River syndrome..  344:1711-1712. 1994
  • Obstetric damage and faecal incontinence..  344:1435. 1994
  • Effect of coronary artery bypass graft surgery on survival..  344:1223. 1994
  • On being poor with HIV..  344:1100-1101. 1994
  • Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura..  344:703-707. 1994
  • Role of selectins in development of adult respiratory distress syndrome..  344:215-219. 1994
  • Clinical application of apolipoprotein E genotyping to Alzheimer's disease..  343:1564-1565. 1994
  • Magnesium and myocardial infarction..  343:1285. 1994
  • Reduced GABA synthesis in pyridoxine-dependent seizures..  343:1133-1134. 1994
  • Sumatriptan-induced stroke in sagittal sinus thrombosis..  343:1105-1106. 1994
  • Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators..  343:881-886. 1994
  • Do non-scientists really live longer?.  343:296. 1994
  • Chronic fetal vascular access..  342:1086-1087. 1993
  • Fertilising ability of testicular spermatozoa..  342:864. 1993
  • Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases..  342:710-711. 1993
  • World Bank's world development report..  342:440. 1993
  • Individual risk assessment for intracranial haemorrhage during thrombolytic therapy.  342:1523-1528. 1993
  • Idiopathic CD4+ T-lymphocytopenia..  340:607-608. 1992
  • Idiopathic CD4+ T-lymphocytopenia..  340:608-609. 1992
  • G-CSF and peripheral blood progenitor cells..  339:1410. 1992
  • Cyclosporin and asthma..  339:873. 1992
  • HIV-1 sensitivity to zidovudine and clinical outcome..  339:626-627. 1992
  • HPV-16-related DNA sequences in Kaposi's sarcoma..  339:515-518. 1992
  • DNA adducts and exposure to burning oil..  339:489. 1992
  • HIV-1 sensitivity to zidovudine and clinical outcome in children..  339:15-19. 1992
  • Phylogeny of the Whipple's-disease-associated bacterium..  338:474-475. 1991
  • Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study..  338:265-269. 1991
  • Medical education in the community: a Nigerian experience..  338:99-102. 1991
  • The acromegalic rosary.  337:860-861. 1991
  • Hypothesis: is lung disease after silicate inhalation caused by oxidant generation?.  336:967-969. 1990
  • Mutations in medium chain acyl-CoA dehydrogenase deficiency..  336:748-749. 1990
  • Induction chemotherapy in Jehovah's Witnesses with leukaemia..  336:563-564. 1990
  • Increase in admissions for Neisseria meningitidis infection in Australia..  2:1464. 1989
  • Bacteriotherapy for clostridium difficile colitis..  2:1096. 1989
  • HYPERBARIC OXYGEN FOR CARBON MONOXIDE POISONING.  334:1032-1033. 1989
  • Hyperbaric for carbon monoxide poisoning..  2:1032-1033. 1989
  • Direct carrier testing in 14 families with haemophilia B..  2:526-529. 1989
  • Zidovudine-induced neutropenia: are we too cautious?.  2:91-92. 1989
  • Patent foramen ovale and decompression sickness in divers..  1:513-514. 1989
  • Importance of electrocardiography for coronary risk factor surveys..  2:633-634. 1988
  • Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals..  1:902-905. 1988
  • Recombinant human granulocyte-macrophage colony-stimulating factor produces fever..  1:950. 1988
  • Tamoxifen versus surgery in elderly patients with breast cancer..  1:891-892. 1988
  • Antibody-dependent enhancement of human immunodeficiency virus type 1 infection..  1:790-794. 1988
  • Adolescent colorectal cancer and dioxin exposure..  2:803. 1987
  • Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex..  1:1286-1292. 1987
  • Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus..  1:890-892. 1987
  • Post-mortem recognition of inherited metabolic disorders from specific acylcarnitines in tissue in cases of sudden infant death..  1:512. 1987
  • Confidentiality and pre-employment health screening..  1:104. 1987
  • Food incentives to improve clinic attendance..  2:230. 1986
  • Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959..  1:1279-1280. 1986
  • Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex..  1:575-580. 1986
  • HTLV-III seroconversion associated with heat-treated factor VIII concentrate..  1:611-612. 1986
  • Playing the odds..  1:329-330. 1985
  • Association between cyclosporin neurotoxicity and hypomagnesaemia..  2:1116-1120. 1984
  • The interictal EEG in diagnosis of epilepsy..  2:518-519. 1984
  • CHILDHOOD DEPRESSION.  323:1409. 1984
  • ANTIGENIC COMPARISON OF VIRUS STRAINS OF MILD AND CLASSICAL TYPES OF EPIDEMIC HAEMORRHAGIC FEVER ISOLATED IN CHINA AND ADAPTATION OF THESE TO CULTURES OF NORMAL CELLS.  323:677-678. 1984
  • Antigenic comparison of virus strains of mild and classical types of epidemic haemorrhagic fever isolated in China and adaptation of these to cultures of normal cells..  1:677-678. 1984
  • Benefits and risks of multiple transfer with in vitro fertilisation..  1:570. 1984
  • Hepatitis B surface antigen could harbour the infective agent of AIDS..  2:882-884. 1983
  • MATCHBOX SIGN.  322:457-458. 1983
  • Viruses of classical and mild forms of haemorrhagic fever with renal syndrome isolated in China have similar bunyavirus-like morphology..  1:589-591. 1983
  • Viruses of classical and mild forms of haemorrhagic fever with renal syndrome isolated in China have similar bunyavirus-like morphology..  1:589-591. 1983
  • Oral typhoid vaccine Ty21a..  1:523. 1983
  • Randomised trial of plasma exchange in mild systemic lupus erythematosus..  1:17-22. 1983
  • Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation..  2:621-623. 1982
  • Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients..  2:354-357. 1982
  • Marrow transplantation for thalassaemia..  2:227-229. 1982
  • Cryptococcosis and the basidiospore..  1:1301. 1982
  • Increased brain-type creatine phosphokinase in marathon runners..  1:1310. 1982
  • Cytomegalovirus retinitis and immunodeficiency in homosexual males..  1:958. 1982
  • Detection bias in endometrial cancer..  1:164. 1982
  • Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis..  1:131-132. 1982
  • Central nervous system leukaemia..  2:633. 1981
  • Kaposi's sarcoma in homosexual men-a report of eight cases..  2:598-600. 1981
  • Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies..  2:66-68. 1981
  • Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development..  1:141-143. 1981
  • Safety and patient acceptability of intravenous immune globulin in 10% maltose..  2:1158-1159. 1980
  • Carpal tunnel syndrome in porphyria..  2:808. 1980
  • Carpal tunnel syndrome in porphyria..  2:808. 1980
  • IgA in saliva of breast-fed and bottle-fed infants..  2:543. 1980
  • Use of antisera for identification of enterotoxigenic Escherichia coli..  2:222-224. 1980
  • VALPROATE, HYPERAMMONÆMIA, AND HYPERGLYCINÆMIA.  316:260-261. 1980
  • Maternal cholera immunisation and scecretory IgA in breast milk..  1:931-932. 1980
  • PROGRESSION OF DIABETIC NEPHROPATHY.  313:1105-1106. 1979
  • Peptic ulcer after renal transplantation..  1:562. 1979
  • Renal transplantation in insulin-requiring diabetics..  1:153. 1979
  • Oral hydration rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution..  2:280-283. 1978
  • Cimetidine and renal-allograft rejection..  1:1154. 1978
  • Legionnaires' disease..  2:1083. 1977
  • Heparin-induced decrease in circulating antithrombin-III..  2:581-584. 1977
  • Meralgia paraesthetica and Epstein-Barr virus..  1:914. 1977
  • Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease..  1:1213-1216. 1976
  • Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh..  1:659-663. 1976
  • Depressed monocyte chemotaxis during acute influenza infection..  2:1063-1066. 1975
  • A continuing common-source outbreak of botulism in a family..  2:861-863. 1975
  • Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli..  2:239-241. 1975
  • Enhanced bactericidal activity of phagocytes from patients with chronic granulomatous disease in the presence of sulphisoxazole..  1:824-827. 1975
  • Bird-mite infestation in a university hospital..  1:445. 1975
  • Outbreak of psychosomatic illness at a rural elementary school..  2:1500-1503. 1974
  • Letter: Incidence of childhood leukaemia..  2:862. 1973
  • Continuous prostaglandin-F 2 infusion for middle-trimester abortion..  1:1195. 1973
  • Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism..  1:631-633. 1973
  • Epstein-Barr virus and Guillain-Barrè syndrome..  1:151. 1973
  • Granulomatous hepatitis associated with acute cytomegalovirus infection..  1:20-22. 1973
  • GRANULOMATOUS HEPATITIS ASSOCIATED WITH ACUTE CYTOMEGALOVIRUS INFECTION.  301:20-22. 1973
  • What causes whooping-cough?.  2:1079. 1970
  • Epidemic shiga dysentery in Central America..  2:661-662. 1970
  • Role of the microvillus in the absorption of disaccharides..  2:154-157. 1968
  • Collagenolytic activity of the skin associated with neuromuscular diseases including amyotrophic lateral sclerosis..  1:1007-1009. 1966
  • DISACCHARIDE INTOLERANCE AND MUCOVISCIDOSIS.  284:120-121. 1964
  • Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy..  361:969. 2003
  • Inherited deletion at Duchenne dystrophy locus in normal male..  1:496-497. 1989
  • Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?.  1:830-831. 1988
  • Inherited deletion at Duchenne dystrophy locus in normal male..  2:1154-1155. 1987
  • Speech therapy for aphasic stroke patients..  1:1413-1414. 1984
  • Ending tuberculosis in the sustainable development era in China: what are the health system challenges? A mixed-methods study 2019
  • Health disparities in tuberculosis incidence, prevalence, and mortality in China (1990 to 2016) using data from the Global Burden of Disease Study 2016: a longitudinal analysis 2019
  • Trends and socioeconomic disparities in financial risk protection in China 2010-16: a repeated cross-sectional analysis 2019
  • Can Jiangsu province achieve the health-related Sustainable Development Goals and Healthy Jiangsu 2030 goals? A systematic analysis on the current situation and projected attainment 2018
  • Does health insurance matter to the use of health services for the elderly in China? A multiyear, nationwide, cross-sectional study 2018
  • Effects of tightening standards for indoor ozone levels on associated mortalities in urban China: a population-based modelling study 2018
  • Equity in health care after 10 years of the New Rural Co-operative Medical Insurance Scheme in China: an analysis of national survey data 2018
  • Residential greenness and mortality in oldest-old women and men in China: a prospective cohort study 2018
  • Effect of coastal marine protection on childhood health: an exploratory study 2017
  • Linear child growth after a natural disaster: a longitudinal study of the effects of the 2004 Indian Ocean tsunami 2017
  • Analysis of the equity of emergency medical services: a cross-sectional survey in Chongqing city 2015
  • Task shifting of traditional birth attendants in rural China: a qualitative study of the implementation of institution-based delivery policy 2015
  • Funding flows to global surgery: an analysis of contributions from the USA. 2015
  • Mapping the playing field-a novel web-based strategy to identify non-governmental actors in global surgery. 2015
  • The first inborn error of manganese metabolism caused by mutations in SLC30A10, a newly identified manganese transporter 2013